Leung · Chronobiology international 2020 · systematic review and meta-analysis · n=15 studies (10 meta-analyzed)

Time of day difference in postprandial glucose and insulin responses: Systematic review and meta-analysis of acute postprandial studies.

Cited 76 times in the scientific literature.

Level 1 - systematic review of randomized trials

Systematic review and meta-analysis of controlled within-subject crossover feeding studies

PubMed 31782659 · doi:10.1080/07420528.2019.1683856 · record verified 2026-08-26

What was done

Authors conducted a systematic review and meta-analysis across seven electronic databases searched through February 2018. Eligible studies evaluated healthy adults who consumed identical test meals during both daytime (07:00–16:00) and nighttime (20:00–04:00) after a minimum 3-hour fast. The primary outcome measures were postprandial glucose and insulin area under the curve (AUC) or incremental AUC (iAUC). Fifteen studies met the inclusion criteria, and 10 were included in the quantitative meta-analyses.

What was found

Meta-analysis demonstrated a significantly lower postprandial glucose response in the daytime compared to nighttime following an identical meal (SMD = -1.66; 95% CI, -1.97 to -1.36; p < .001). Daytime postprandial insulin response was also significantly lower than at night (SMD = -0.35; 95% CI, -0.63 to -0.06; p = .016). Studies ineligible for quantitative synthesis qualitatively supported lower daytime glucose, but qualitative findings for insulin were inconsistent.

Why it matters

This meta-analysis demonstrates that human glucose tolerance is significantly impaired during the biological night compared to daytime. These circadian metabolic differences offer a physiological mechanism linking habitual night eating and shift work to higher rates of cardiometabolic disorders.

Limits

The abstract does not report the total participant sample size across the 15 studies. Included data reflect acute laboratory feeding protocols in healthy adults, limiting direct extrapolation to free-living chronic outcomes or individuals with metabolic disease. Insulin findings were inconsistent among studies not included in the numerical meta-analysis.

Cited by